⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 17, 2018Science Translational MedicineOpen Access

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus

View Full Paper

Ask AI

Bookmark

Share

Abstract

DNA methylation enables an efficient, well-tolerated, sensitive, and specific method of screening at-risk populations for BE.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Moinova et al. (2018) studied this question.

synapsesocial.com/papers/6a718da2e5469ee92be207b6 https://doi.org/10.1126/scitranslmed.aao5848

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Methylomics analysis identifies epigenetically silenced genes and implies an activation of β‐catenin signaling in cervical cancerOriginal Research · 2013 · 72 citations
2DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2 /p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast TumorsPrognostic Study · 2014 · 56 citations
3Circulating cell-free DNA-based epigenetic assay can detect early breast cancerCase-Control Study · 2016 · 117 citations
4Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with gliomaOriginal Research · 2011 · 21 citations
5Advances in the management of Barrett’s esophagus and early esophageal adenocarcinomaReview · 2015 · 9 citations